Articles
AusCann Group Holdings Limited

AusCann Group Holdings Limited


AusCann is a Western Australian Pharmaceutical company that focuses on producing high-quality medical-grade cannabis medicines. They are licensed to cultivate, manufacture and supply medicinal cannabis.

They have a very strong public image when it comes to the production of cannabis medicines for neuropathic and chronic pain. They focus on the “farm to pharmacy” model that makes access to their products easier for Australians.

They are focusing on securing distribution partners with strong pre-existing patient bases and education of medical practitioners on the benefits and treatment of medicinal cannabis in Australia.

The CEO, Ido Kanyon, has over ten years of experience in the North American pharmaceutical industry and has brought sharp focus to the Perth cannabis company to ensure opportunities aren’t missed as the industry expands.

Company Information
Type: Manufacturer
Products: CBD and THC Oils
Opened: 12/02/2013
CEO: Ido Kanyon
Employees: 32
Revenue: $6.7M
Website: https://www.auscann.com.au/
Phone: 08 9561 8834
Email: info@auscann.com.au
Address: Suite 8, Level 2, 57 Shenton Avenue, Joondalup, Western Australia 6033




Disclaimer: Cannabis Place may contain information regarding cannabis & other drugs; it is designed for 18+ audiences in regions where cannabis has been decriminalised. This topic may represent illegal activity in certain regions. We do not encourage illegal activity. We understand that readers in locations where cannabis has been legalised may read these articles. Medical Cannabis in Australia is regulated by the Therapeutic Goods Administration and details about Cannabis as a scheduled drug can be found on their website. Please consult with your doctor to find out if Cannabis is right for you. Click here for our full disclaimer